
Bristol Myers Squibb (NYSE: BMY)
Bristol Myers Squibb Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Bristol Myers Squibb Company Info
Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.
News & Analysis
Bristol Myers Squibb Tops Q4 Estimates
Bristol Myers Squibb reported strong fourth-quarter earnings but its outlook for 2025 failed to meet expectations.
2 High-Yield Dividend Stocks to Hold Through 2025 and Beyond
5 Best Dividend Mutual Funds
A closer look at some of the top dividend mutual funds for yield-seeking investors.
3 Cheap Dividend Stocks That Pay More Than Double the S&P 500 Average
This Unpopular Dividend Stock Is a Buy
2 High-Yield Dividend Stocks to Buy Early in 2025
3 High-Yielding Dividend Stocks That Retirees Can Rely On for Recurring Income
Got $250? 2 Healthcare Stocks to Buy and Hold Forever
Valuation
Podcast Episodes

The Top Biotech Stocks to Watch Following ASH 2019
The potential to reshape treatment of blood cancer and disorders could mean big bucks for these companies.

3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year
These stocks skyrocketed following exciting announcements.
Carl Icahn Takes Aim at Bristol-Myers Squibb
Carl Icahn's reportedly focusing his brand of investor activism on Bristol-Myers Squibb, but it's anyone's guess if he'll be able to convince the company to sell. Also, Celgene delivers a phase 3 win with blockbuster implications.
Heart-Thumping, Game-Changing Ways We're Treating Cardiovascular Disease
In this Valentine's Day edition, Industry Focus explores cholesterol busters, heart surgery, and the latest in anticoagulants.
Earnings Transcripts
Bristol Myers Squibb (BMY) Q4 2024 Earnings Call Transcript
BMY earnings call for the period ending December 31, 2024.
Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript
BMY earnings call for the period ending September 30, 2024.
Bristol Myers Squibb (BMY) Q2 2024 Earnings Call Transcript
BMY earnings call for the period ending June 30, 2024.
Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript
BMY earnings call for the period ending March 31, 2024.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.